Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Jason Dehn, Stephen Spellman, Carolyn K. Hurley, Bronwen E. Shaw, Juliet N. Barker, Linda J. Burns, Dennis L. Confer, Mary Eapen, Marcelo Fernandez-Vina, Robert Hartzman, Martin Maiers, Susana R. Marino, Carlheinz Mueller, Miguel-Angel Perales, Raja Rajalingam, Joseph Pidala

Blood (2019) 134 (12): 924–934.

https://doi.org/10.1182/blood.2019001212

Published: 2019

Journal Articles

Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion

Blood (2018) 131 (11): 1248–1257.

https://doi.org/10.1182/blood-2017-07-798751

Published: 2018

Includes: Supplemental data

Journal Articles

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

Michael A. Spinner, MD, Marcelo Fernandez Vina, PhD, Linda Elder, BA, Sally Arai, MD, Laura Johnston, MD, Everett Meyer, MD PhD, David Miklos, MD PhD, Lori Muffly, MD, Robert S. Negrin, MD, Judith Shizuru, MD PhD, Wen-Kai Weng, MD PhD, Ginna G. Laport, MD, Samuel Strober, MD, Robert Lowsky, MD, Andrew R. Rezvani, MD

Blood (2016) 128 (22): 4669.

https://doi.org/10.1182/blood.V128.22.4669.4669

Published: 2016

Journal Articles

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

Blood (2016) 127 (2): 260–267.

https://doi.org/10.1182/blood-2015-08-663823

Published: 2016

Journal Articles

Increased Disease Progression in HLA-a, -B, -C, -DRB1 and -DBP1 Matched Recipients of Unrelated Donor Transplants with Peripheral Blood Is Independent of Risk Groups By Disease Risk Index

Betul Oran, MD, Rima M Saliba, PhD, Yudith Carmazzi, Elizabeth J. Shpall, MD, Katayoun Rezvani, MD, PhD, Marcos De Lima, MD, Marcelo Fernández-Viña, Richard E. Champlin, MD, Kai Cao, MS, MD

Blood (2015) 126 (23): 2005.

https://doi.org/10.1182/blood.V126.23.2005.2005

Published: 2015

Journal Articles

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Blood (2014) 124 (16): 2596–2606.

https://doi.org/10.1182/blood-2014-05-576041

Published: 2014

Journal Articles

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

Blood (2013) 122 (22): 3651–3658.

https://doi.org/10.1182/blood-2013-05-501510

Published: 2013

Includes: Supplemental data

Journal Articles

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Blood (2012) 120 (21): 467.

https://doi.org/10.1182/blood.V120.21.467.467

Published: 2012

Journal Articles

Definitions of histocompatibility typing terms

Eduardo Nunes, Helen Heslop, Marcelo Fernandez-Vina, Cynthia Taves, Dawn R. Wagenknecht, A. Bradley Eisenbrey, Gottfried Fischer, Kay Poulton, Kara Wacker, Carolyn Katovich Hurley, Harriet Noreen, Nicoletta Sacchi

Blood (2011) 118 (23): e180–e183.

https://doi.org/10.1182/blood-2011-05-353490

Published: 2011

Journal Articles

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation

Stefan O. Ciurea, Peter F. Thall, Xuemei Wang, Sa A. Wang, Ying Hu, Pedro Cano, Fleur Aung, Gabriela Rondon, Jeffrey J. Molldrem, Martin Korbling, Elizabeth J. Shpall, Marcos de Lima, Richard E. Champlin, Marcelo Fernandez-Vina

Blood (2011) 118 (22): 5957–5964.

https://doi.org/10.1182/blood-2011-06-362111

Published: 2011

Journal Articles

HLA matching of CB: it's complicated

Marcos de Lima, Marcelo Fernandez-Vina, Elizabeth J. Shpall

Blood (2011) 118 (14): 3761–3762.

https://doi.org/10.1182/blood-2011-08-369066

Published: 2011

Journal Articles

Superior Outcomes with Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors In Allogeneic Hematopoietic Stem Cell Transplantation

Stefan O. Ciurea, MD, Rima M. Saliba, PhD, Gabriela Rondon, MD, Poliana A. Patah, MD, Fleur Aung, Borje S. Andersson, MD, Partow Kebriaei, MD, Uday Popat, MD, Marcelo Fernandez-Vina, PhD, Richard E. Champlin, MD, Marcos de Lima

Blood (2010) 116 (21): 907.

https://doi.org/10.1182/blood.V116.21.907.907

Published: 2010

Journal Articles

Mesenchymal Stem Cell (MSC) Based Cord Blood (CB) Expansion (Exp) Leads to Rapid Engraftment of Platelets and Neutrophils

Blood (2010) 116 (21): 362.

https://doi.org/10.1182/blood.V116.21.362.362

Published: 2010

Journal Articles

Outcomes of Patients Treated with Matched and Mismatched Unrelated Donors Using High-Resolution HLA Typing at 12 Loci

Stefan O. Ciurea, MD, Rima M. Saliba, PhD, Gabriela Rondon, MD, Poliana A. Patah, MD, Morgani Rodrigues, MD, Fleur M. Aung, MD, Borje S. Andersson, MD, Simrit Parmar, MD, Richard E. Champlin, MD, Marcos de Lima, MD, Marcelo Fernandez-Vina

Blood (2010) 116 (21): 3537.

https://doi.org/10.1182/blood.V116.21.3537.3537

Published: 2010

Journal Articles

Anti-HLA Antibodies and Graft Rejection In Hematopoietic Stem Cell Transplantation

Stefan O. Ciurea, MD, Fleur Aung, MD, Marcos de Lima, MD, Peter F. Thall, PhD, Gabriela Rondon, MD, Partow Kebriaei, MD, Amin Alousi, MD, Elizabeth J. Shpall, MD, Chitra Hosing, MD, Issa F Khouri, MD, Richard E. Champlin, MD, Marcelo Fernandez-Vina, PhD

Blood (2010) 116 (21): 519.

https://doi.org/10.1182/blood.V116.21.519.519

Published: 2010

Journal Articles

Alloreactive Nk Cells to Augment Antileukemia Cytotoxicity with Allogeneic Stem Cell Transplantation for Aml/Mds: A Phase I Study

Richard Champlin, Dean A. Lee, MD, PhD, Marcelo Fernandez-Vina, PhD, Gabriela Rondon, MD, Patricia McAdams, RN, Chen Julianne, Muzaffar H. Qazilbash, MD, Partow Kebriaei, MD, Simrit Parmar, MBBS, Elizabeth J. Shpall, Uday Popat, MD, Amin Alousi, MD, Stefan O. Ciurea, MD, Laurence Cooper, MD, PhD, Thall Peter, John McMannis, PhD

Blood (2010) 116 (21): 489.

https://doi.org/10.1182/blood.V116.21.489.489

Published: 2010

Journal Articles

HLA Homozygosity and Haplotype Bias Among Patients with Chronic Lymphocytic Leukemia: Implications for Disease Control by Physiologic Immune Surveillance

Nina Shah, MD, William Decker, Ruth Lapushin, Dongxia Xing, Simon Robinson, PhD, Hong Yang, PHD, Simrit Parmar, M.D., Shawndeep Tung, MD, Susan O'Brien, Marcelo Fernandez-Vina, Elizabeth J. Shpall, William G. Wierda, MD, PhD

Blood (2010) 116 (21): 1370.

https://doi.org/10.1182/blood.V116.21.1370.1370

Published: 2010

Journal Articles

Human-Leukocyte-Histocompatibility Antigens Predict Response to Rituximab and Donor Lymphocyte Infusion (DLI) After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL)

Issa F. Khouri, Roland Bassett, Pedro Cano, Susan O'Brien, Yvonne Hsu, Carlos E. Bueso-Ramos, Robyn Harrell, Grace-Julia Okoroji, Leandro de Padua Silva, Alessandra Ferrajoli, Richard Champlin, John McMannis, Marcelo Fernandez-Vina

Blood (2010) 116 (21): 2548.

https://doi.org/10.1182/blood.V116.21.2548.2548

Published: 2010

Journal Articles

Human-Leukocyte-Histocompatibility Antigens (HLA-A1+, A2-, B44-) and Serum Immunoglobulin (Ig)G with CD4 Levels Predict Response to Graft-Versus-Leukemia (GVL) and Overall Survival, Respectively, After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL).

Issa F Khouri, Roland L Bassett, Jr., Pedro Cano, Susan O'Brien, Yvonne Hsu, Carlos E Bueso-Ramos, Robyn Harrell, Grace-Julia Okoroji, Leandro De Padua Silva, Alessandra Ferrajoli, William Wierda, Hagop Kantarjian, Richard Champlin, John McMannis, Marcelo Fernandez-Vina

Blood (2009) 114 (22): 2287.

https://doi.org/10.1182/blood.V114.22.2287.2287

Published: 2009

Journal Articles

Rapid Engraftment of Neutrophils and Platelets with Mesenchymal Stem Cell Based Cord Blood (CB) Expansion (EXP).

Blood (2009) 114 (22): 3394.

https://doi.org/10.1182/blood.V114.22.3394.3394

Published: 2009

NARROW

Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR

Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion

Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors

The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy

Increased Disease Progression in HLA-a, -B, -C, -DRB1 and -DBP1 Matched Recipients of Unrelated Donor Transplants with Peripheral Blood Is Independent of Risk Groups By Disease Risk Index

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality

Amino Acid Substitution At Peptide-Binding Pockets of HLA Class I Molecules Adversely Impacts Hematopoietic Cell Transplantation Outcomes

Definitions of histocompatibility typing terms

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation

HLA matching of CB: it's complicated

Superior Outcomes with Matched Unrelated Donors Compared with One Human Leukocyte Antigen Mismatched Related Donors In Allogeneic Hematopoietic Stem Cell Transplantation

Mesenchymal Stem Cell (MSC) Based Cord Blood (CB) Expansion (Exp) Leads to Rapid Engraftment of Platelets and Neutrophils

Outcomes of Patients Treated with Matched and Mismatched Unrelated Donors Using High-Resolution HLA Typing at 12 Loci

Anti-HLA Antibodies and Graft Rejection In Hematopoietic Stem Cell Transplantation

Alloreactive Nk Cells to Augment Antileukemia Cytotoxicity with Allogeneic Stem Cell Transplantation for Aml/Mds: A Phase I Study

HLA Homozygosity and Haplotype Bias Among Patients with Chronic Lymphocytic Leukemia: Implications for Disease Control by Physiologic Immune Surveillance

Human-Leukocyte-Histocompatibility Antigens Predict Response to Rituximab and Donor Lymphocyte Infusion (DLI) After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL)

Human-Leukocyte-Histocompatibility Antigens (HLA-A1+, A2-, B44-) and Serum Immunoglobulin (Ig)G with CD4 Levels Predict Response to Graft-Versus-Leukemia (GVL) and Overall Survival, Respectively, After Non-Myeloablative Allogeneic Stem Transplantation (NST) for Chronic Lymphocytic Leukemia (CLL).

Rapid Engraftment of Neutrophils and Platelets with Mesenchymal Stem Cell Based Cord Blood (CB) Expansion (EXP).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only